Subjective symptoms and pharmacokinetics
β
E. S. DimenΓ€s; C. G. DahlΓΆf; B. Heibel; R. G. Moore; B. K. Olofsson; G. E. Weste
π
Article
π
1990
π
Springer
π
English
β 767 KB
In a double-blind, randomised, cross-over study, the pharmacokinetic/dynamic effects and subjective symptoms of a new controlled-release (CR) formulation of metoprolol (50 and 100 mg) have been compared with atenolol (50 mg) and placebo in 20 elderly healthy subjects. The metoprolol CR formulation d